Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IFOSFAMIDE for Diffuse large b-cell lymphoma refractory: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 111 adverse event reports in the FDA FAERS database where IFOSFAMIDE was used for Diffuse large b-cell lymphoma refractory.

Most Reported Side Effects for IFOSFAMIDE

Side Effect Reports % Deaths Hosp.
Off label use 2,281 13.4% 486 629
Febrile neutropenia 2,225 13.1% 228 1,165
Disease progression 1,912 11.2% 515 198
Neutropenia 1,509 8.9% 173 417
Drug ineffective 1,331 7.8% 416 317
Thrombocytopenia 1,227 7.2% 140 317
Anaemia 1,067 6.3% 94 365
Product use in unapproved indication 890 5.2% 190 183
Pyrexia 752 4.4% 107 493
Sepsis 712 4.2% 406 273
Malignant neoplasm progression 671 4.0% 210 120
Infection 649 3.8% 177 113
Pancytopenia 632 3.7% 144 270
Encephalopathy 585 3.4% 72 287
Vomiting 570 3.4% 80 274

Other Indications for IFOSFAMIDE

Diffuse large b-cell lymphoma (2,425) Ewing's sarcoma (937) Product used for unknown indication (910) Osteosarcoma (845) B-cell lymphoma (541) Hodgkin's disease (533) Burkitt's lymphoma (472) Non-hodgkin's lymphoma (434) Chemotherapy (429) Central nervous system lymphoma (394)

Other Drugs Used for Diffuse large b-cell lymphoma refractory

RITUXIMAB (667) EPCORITAMAB-BYSP (353) AXICABTAGENE CILOLEUCEL (336) BENDAMUSTINE (283) CYCLOPHOSPHAMIDE (226) POLATUZUMAB VEDOTIN (223) ETOPOSIDE (165) POLATUZUMAB VEDOTIN-PIIQ (158) GEMCITABINE (147) LENALIDOMIDE (143)

Related Pages

IFOSFAMIDE Full Profile All Diffuse large b-cell lymphoma refractory Drugs IFOSFAMIDE Demographics IFOSFAMIDE Timeline